Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-12

Clinical Trial Update: Safety & Effectiveness Study of AEGEA Vapor System to Treat Excessive Uterine Bleeding [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 safety and effectiveness trial of the AEGEA Vapor System for treating menorrhagia (excessive uterine bleeding). The trial's curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AEGEA Vapor System

Snippet

Sponsor: Aegea Medical, Inc. | Conditions: Menorrhagia | Phase 3 | Status: UNKNOWN